An updated review of the long-term neurological effects of galactosemia

Pediatric Neurology

Volumn 33, Issue 3, 2005, Pages 153-161

  Ridel, Keith R ^a   Leslie, Nancy D ^b   Gilbert, Donald L ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

APRAXIA; ATAXIA; AUTOSOMAL RECESSIVE DISORDER; COGNITION; COGNITIVE DEFECT; DIET; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME RELEASE; GALACTOSEMIA; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; INTRACRANIAL PRESSURE; MASS SPECTROMETRY; MENTAL DISEASE; NEUROLOGIC DISEASE; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SEIZURE; TREATMENT OUTCOME; TREMOR; WHITE MATTER;

EID: 27644434993     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2005.02.015     Document Type: Review

References (91)

1. von Reuss A. Zuckerausscheidung in säuglinsalter. Wein Med Wschr 1908;58:799-800.
2. Komrower GM, Schwartz RP, Holzel A, Golberg A. A clinical and biochemical study of galactosaemia: A possible explanation for the nature of the biochemical lesion. Arch Dis Child 1956;31:254-64.
3. Kalckar H, Anderson E, Isselbacher K. Galactosemia, a congenital defect in a nucleotide transferase. Biochim Biophys Acta 1956;20:262-8.
4. Mason H, Turner M. Chronic galactosemia. Am J Dis Child 1935;50:359-74.
5. Beutler E, Baluda M, Donnell G. A new method for the detection of galactosemia and its carrier state. J Lab Clin Med 1964;64:694-705.
6. Gitzelmann R, Steinmann B. Galactosemia: How does long-term treatment change the outcome? Enzyme 1984;32:37-46.
7. Lo W, Packman S, Nash S, et al. Curious neurologic sequelae in galactosemia. Pediatrics 1984;73:309-12.
8. Waggoner D, Buist N, Donnell G. Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J Inher Metab Dis 1990;13:802-18.
9. Schweitzer S, Shin Y, Jakobs C, Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 1993;152:36-43.
10. Murphy M, McHugh B, Tighe O, et al. Genetic basis of transferase- deficient galactosaemia in Ireland and the population history of the Irish Travellers. Eur J Hum Genet 1999;7:549-54.
11. Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I, Isshiki G. Molecular basis for phenotypic heterogeneity in galactosaemia: Prediction of clinical phenotype from genotype in Japanese patients. Eur J Hum Genet 1999;7:757-64.
12. Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ. The human galactose-1-phosphate uridyltransferase gene. Genomics 1992;14:474-80.
13. Fridovich-Keil JL, Langley SD, Mazur LA, Lennon JC, Dembure PP, Elsas JL 2nd. Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family [see comment]. Am J Hum Genet 1995;56:640-6.
14. Ross KL, Davis CN, Fridovich-Keil JL. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. Molec Genet Metab 2004;83:103-16.
15. Henderson H, Leisegang F, Brown R, Eley B. The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa. BMC Pediatrics 2002;2:7.
16. Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ 2nd. A prevalent mutation for galactosemia among black Americans. J Pediatr 1996;128:89-95.
17. Lai K, Elsas LJ. Structure-function analyses of a common mutation in blacks with transferase-deficiency galactosemia. Molec Genet Metab 2001;74:264-72.
18. Yager C, Gibson J, States B, Elsas LJ, Segal S. Oxidation of galactose by galactose-1-phosphate uridyltransferase-deficient lymphoblasts. J Inherit Metab Dis 2001;24:465-76.
19. Elsas LJ 2nd, Lai K. The molecular biology of galactosemia. Genetics in Medicine 1998;1:40-8.
20. Kelley R, Segal S. Evaluation of reduced activity galactose-1-phosphate uridyl transferase by combined radioisotopic assay and high-resolution isoelectric focusing. J Lab Clin Med 1989;114:152-6.
21. Levy HL, Brown AE, Williams SE, de Juan E Jr. Vitreous hemorrhage as an ophthalmic complication of galactosemia. J Pediatr 1996;129:922-5.
22. Segal S. Komrower Lecture. Galactosaemia today: The enigma and the challenge. J Inherit Metab Dis 1998;21:455-71.
23. Shah V, Friedman S, Moore AM, Platt BA, Feigenbaum AS. Selective screening for neonatal galactosemia: An alternative approach. Acta Paediatrica 2001;90:948-9.
24. Walter J, Collins J, Leonard J. Recommendations for the management of galactosemia. Arch Dis Child 1999;80:93-6.
25. Flanagan JM, Tighe O, O'Neill C, Naughten E, Mayne PD, Croke DT. Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLC. Molec Genet Metab 2004;81:133-6.
26. Jakobs C, Kleijer W, Allen J, Holton J. Prenatal diagnosis of galactosemia. Eur J Pediatr 1995;154:S33-6.
27. Kaufman F, Kogut M, Donnell G, Goebelsmann U, March C, Koch R. Hypergonadotrpic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-8.
28. de Jongh S, Vreken P, Ijst L, Wanders R, Jakobs C, Bakker H. Spontaneous pregnancy in a patient with classical galactosemia. J Inher Metab Dis 1999;22:754-5.
29. Gibson J. Gonadal function in galactosemics and in galactose-intoxicated animals. Eur J Pediatr 1995;154:S14-20.
30. Prestoz LL, Couto AS, Shin YS, Petry KG. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur J Pediatr 1997;156:116-20.
31. Huttenlocher P, Hillman R, Hsia Y. Pseudotumor cerebri in galactosemia. J Pediatr 1970;76:902-5.
32. Knull H, Wells W, Kozak L. Galactose toxicity in the chick: Hyperosmolality or depressed brain energy reserves? Science 1972;176: 815-6.
33. Wang ZI, Berry GT, Dreha SF, Zhao H, Segal S, Zimmerman RA. Proton magnetic resonance spectroscopy of brain metabolites in galactosemia. Ann Neurol 2001;50:266-9.
34. Belman A, Moshe S, Zimmerman R. Computed tomographic demonstration of cerebral edema in a child with galactosemia. Pediatrics 1986;78:606-9.
35. Myers R, Powell H. Galactose neuropathy: Impact of chronic endoneurial edema on nerve blood flow. Ann Neurol 1984;16:587-94.
36. Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HS, Wijburg FA, Last BF. Living with classical galactosemia: Health-related quality of life consequences. Pediatrics 2004;113:e423-8.
37. Cleary M, Heptinstall L, Wraith J, Walter J. Galactosemia: Relationship of IQ to biochemical control and genotype. J Inher Metab Dis 1995;18:151-2.
38. Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 1995;154:S2-5.
39. Koch T, Schmidt K, Wagstaff J, Ng W, Packman S. Neurologic complications in galactosemia. Pediatr Neurol 1992;8:217-20.
40. Shield J, Wadsworth E, MacDonald A, et al. The relationship of genotype to cognitive outcome in galactosemia. Arch Dis Child 2000; 83:248-50.
41. Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: A descriptive study. Neuropsychology 2004;18:658-64.
42. Kaufman FR, Reichardt JK, Ng WG, et al. Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pediatr 1994; 125:225-7.
43. Fishier K, Koch R, Donnell GN, Wenz E. Developmental aspects of galactosemia from infancy to childhood. Clin Pediatr 1980; 19:38-44.
44. Nelson D, Waggoner D, Donnell G, Tuerck J, Buist N. Verbal dyspraxia in treated galactosemia. Pediatrics 1991;88:346-50.
45. Nelson D. Verbal dyspraxia in children with galactosemia. Eur J Pediatr 1995;154:S6-7.
46. Pannbacker M. Management strategies for developmental apraxia of speech: A review of literature. J Communica Disord 1988;21: 363-71.
47. Bohles H, Wenzel D, Shin Y. Progressive cerebellar and extrapyramidal motor disturbances in galactosemic twins. Eur J Pediatr 1986;145:413-7.
48. Friednian J, Levy H, Boustany R. Late onset of distinct neurologic syndromes in galactosemic siblings. Neurology 1989;39: 741-2.
49. Jan J, Wilson R. Unusual late neurological sequelae in galactosemia. Dev Med Child Neurol 1973;15:72-4.
50. Van Heyningen R. Formation of polyols by the lens of the rat with "sugar" cataracts. Nature 1959;184:194-5.
51. Cuatrecasas P, Segal S. Galactose conversion to d-xylulose: An alternate route of galactose metabolism. Science 1966;153:549-51.
52. Petry K, Greinix HT, Nudelman E, et al. Characterization of a novel biochemical abnormality in galactosemia: Deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem Med Metab Biol 1991; 46:93-104.
53. Quan-Ma R, Wells HJ, Wells WW, Sherman FE, Egan TJ. Galactitol in the tissues of a galactosemic child. Am J Dis Child 1966;112:477-8.
54. Acosta P, Gross K. Hidden sources of galactose in the environment. Eur J Pediatr 1995;154:S87-92.
55. Berry G, Nissim I, Lin Z, Mazur A, Gibson J, Segal S. Endogenous synthesis of galactose in normal men and patients with hereditary galactosemia. Lancet 1995;346:1073-4.
56. Holton J. Effects of galactosemia in utero. Eur J Pediatr 1995;154:S77-81.
57. Irons M, Levy H, Pueschel S, Castree K. Accumulation of galactose-1-phosphate in the galactosemic fetus despite maternal milk avoidance. J Pediatr 1985;107:261-3.
58. Jakobs C, Kleijer W, Bakker H, Van Gennip A, Przyrembel H, Niermeijer M. Dietary restriction of maternal lactose intake does not prevent accumulation of galactitol in the amniotic fluid of fetuses affected with galactosemia. Prenatal Diagn 1988;8:641-5.
59. 31P magnetic resonance spectroscopy. Eur J Pediatr 1995;154:S8-13.
60. Webb AL, Singh RH, Kennedy MJ, Elsas LJ. Verbal dyspraxia and galactosemia. Pediatr Res 2003;53:396-402.
61. Stewart M, Kurien M, Sherman W, Cotlier E. Inositol changes in nerve and lens of galactose fed rats. J Neurochem 1968;15:941-6.
62. Wells H, Wells W. Galactose toxicity and myo-inositol metabolism in the developing rat brain. Biochemistry 1967;6:1168-73.
63. Warfield A, Segal S. Myo-inositol and phosphatidylinositol in synaptosomes from galactose-fed rats. Proc Natl Acad Sci 1978;75:45-68.
64. Sugimoto K, Kasahara T, Yonezawa H, Yagihashi S. Peripheral nerve structure and function in long-term galactosemic dogs: Morphometric and electron microscopic analyses. Acta Neuropathol (Berl) 1999;97:369-76.
65. Segal S. The enigma of galactosemia. Internat Pediatr 1992;7: 75-82.
66. Leslie ND, Yager KL, McNamara PD, Segal S. A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Molec Med 1996:59:7-12.
67. Ning C, Reynolds R, Chen J, et al. Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 2000;48:211-7.
68. Crome L. A case of galactosemia with the pathological and neuropathological findings. Arch Dis Child 1962;37:415-21.
69. Rogers S, Heidenreich R, Mallee J, Segal S. Regional activity of galactose-1-phosphate uridyltransferase in rat brain. Pediatr Res 1992;31:512-5.
70. Haberland C, Perou M, Brunngraber EG, Hof H. The neuropathology of galactosemia: A histopathological and biochemical study. J Neuropathol Exp Neurol 1971;30:431-47.
71. Nelson M, Wolff J, Cross C, Donnell G, Kaufman F. Galactosemia: Evaluation with MR imaging. Radiology 1992;184:255-61.
72. Segal S. Defective galactosylation in galactosemia: Is low cell UDPgalactose an explanation? Eur J Pediatr 1995;154:S65-71.
73. Kaufman FR, Horton EJ, Gott P, et al. Abnormal somatosensory evoked potentials in patients with classic galactosemia: Correlation with neurologic outcome. J Child Neurol 1995;10:32-6.
74. Elsas L, Fridovich-Keil J, Leslie N. Galactosemia: A molecular approach to the enigma. Internat Pediatr 1993;8:101-8.
75. Elsas L, Langley S, Paulk E, Hjelm L, Dembure P. A molecular approach to galactosemia. Eur J Pediatr 1995;154:S21-7.
76. Scriver CR, Waters PJ. Monogenic traits are not simple: Lessons from phenylketonuria. Trends in Genetics 1999;15:267-72.
77. Dipple KM, McCabe ER. Modifier genes convert "simple" Mendelian disorders to complex traits. Molec Genet Metab 2000;71:43-50.
78. Ning C, Fenn PT, Blair IA, Berry GT, Segal S. Apparent galactose appearance rate in human galactosemia based on plasma [(13)C]galactose isotopic enrichment. Molec Genet Metab 2000;70:261-71.
79. Schadewaldt P, Hammen HW, Loganathan K, Bodner-Leidecker A, Wendel U. Analysis of concentration and (13)C enrichment of D-galactose in human plasma. Clin Chem 2000;46:612-9.
80. Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U. Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Molec Genet Metab 2004;81:31-44.
81. Berry GT, Moate PJ, Reynolds RA, et al. The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Molec Genet Metab 2004;81:22-30.
82. Berry GT, Palmieri M, Gross KC, et al. The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inher Metab Dis 1993;16:91-100.
83. Bosch AM, Bakker HD, Wenniger-Prick LJ, Wanders RJ, Wijburg FA. High tolerance for oral galactose in classical galactosaemia: Dietary implications. Arch Dis Child 2004;89:1034-6.
84. Kaufman F, Loro M, Azen C, Wenz E, Gilsanz V. Effect of hypogonadism and deficient calcium intake on bone density in patients with galactosemia. J Pediatr 1993;123:365-70.
85. Panis B, Forget PP, van Kroonnburgh MJ, et al. Bone metabolism in galactosemia. Bone 2004;35:982-7.
86. Clouds over galactosemia. Lancet 1982;2:1379-80.
87. Lee PJ, Lilburn M, Wendel U, Schadewaldt P. A woman with untreated galactosaemia. [erratum appears in Lancet. 2004 Jul 24; 364(9431):330]. Lancet 2003;362:446.
88. Schadewaldt P, Lilburn M, Wendel U, Lee PJ. Unexpected outcome in untreated galactosaemia, Reply. Molec Genet Metab 2004; 81:255-7.
89. Segal S. Another aspect of the galactosemia enigma. Molec Genet Metab 2004;81:253-4.
90. Manis FR, Cohn LB, McBride-Chang C, Wolff JA, Kaufman FR. A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine. J Inher Metab Dis 1997;20:549-55.
91. Ng WG, Xu YK, Kaufman FR, Donnell GN. Deficit of uridine diphosphate galactose in galactosaemia. J Inher Metab Dis 1989;12:257-66.